Abstract

The aim of this study was to evaluate the benefit of a volumetric AI-based body composition analysis (BCA) algorithm in multiple myeloma (MM). Therefore, a retrospective monocentric cohort of 91 MM patients was analyzed. The BCA algorithm, powered by a convolutional neural network, quantified tissue compartments and bone density based on routine CT scans. Correlations between BCA data and demographic/clinical parameters were investigated. BCA-endotypes were identified and survival rates were compared between BCA-derived patient clusters. Patients with high-risk cytogenetics exhibited elevated cardiac marker index values. Across Revised-International Staging System (R-ISS) categories, BCA parameters did not show significant differences. However, both subcutaneous and total adipose tissue volumes were significantly lower in patients with progressive disease or death during follow-up compared to patients without progression. Cluster analysis revealed two distinct BCA-endotypes, with one group displaying significantly better survival. Furthermore, a combined model composed of clinical parameters and BCA data demonstrated a higher predictive capability for disease progression compared to models based solely on high-risk cytogenetics or R-ISS. These findings underscore the potential of BCA to improve patient stratification and refining prognostic models in MM.

Original languageEnglish
Article number26455
JournalScientific Reports
Volume15
Issue number1
ISSN2045-2322
DOIs
Publication statusPublished - 12.2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 9 - Industry, Innovation, and Infrastructure
    SDG 9 Industry, Innovation, and Infrastructure

Research Areas and Centers

  • Centers: Center for Artificial Intelligence Luebeck (ZKIL)
  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)
  • Academic Focus: Biomedical Engineering
  • Research Area: Luebeck Integrated Oncology Network (LION)

DFG Research Classification Scheme

  • 2.21-05 Immunology
  • 2.22-07 Medical Informatics and Medical Bioinformatics
  • 2.22-32 Medical Physics, Biomedical Technology
  • 2.22-18 Rheumatology
  • 2.22-14 Hematology, Oncology
  • 4.43-04 Artificial Intelligence and Machine Learning Methods

Fingerprint

Dive into the research topics of 'AI-based body composition analysis of CT data has the potential to predict disease course in patients with multiple myeloma'. Together they form a unique fingerprint.

Cite this